Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors

PURPOSE: Paclitaxel, ifosfamide, and cisplatin (TIP) achieved complete responses (CRs) in two thirds of patients with advanced germ cell tumors (GCTs) who relapsed after first-line chemotherapy with cisplatin and etoposide with or without bleomycin. We tested the efficacy of first-line TIP in patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Feldman, Darren R., Hu, James, Dorff, Tanya B., Lim, Kristina, Patil, Sujata, Woo, Kaitlin M., Carousso, Maryann, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit, Daneshmand, Siamak, Ketchens, Charlene, Bajorin, Dean F., Bosl, George J., Quinn, David I., Motzer, Robert J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2016
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320896/
https://ncbi.nlm.nih.gov/pubmed/27185842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.7899
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi